Quantcast

Latest Cholesterol Stories

2014-03-31 12:28:19

Findings Presented at the American College of Cardiology Annual Meeting Using the VAP® Lipid Panel Highlight Connection between Lipoproteins and Risk of Coronary Heart Disease WASHINGTON, March 31, 2014 /PRNewswire/ -- Data presented from two meta-analyses using the Atherotech Vertical Auto Profile (VAP(®))( )Lipid Panel showed the impact high-density lipoprotein (HDL) cholesterol and remnant lipoprotein (RLP) cholesterol have on determining a patient's risk for hard coronary heart...

2014-03-31 12:28:14

Data demonstrates that the NMR LipoProfile® test provides clinically reliable information to help reduce cardiovascular events, especially in patients with diabetes and those on statin therapy WASHINGTON, March 31, 2014 /PRNewswire/ -- LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced data showing that...

2014-03-31 12:28:11

- Reductions of up to 64 percent in triglycerides achieved CARLSBAD, Calif., March 31, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced the final results from its Phase 2 study of ISIS-APOCIII(Rx) in patients with high to severely high triglycerides on stable doses of fibrates. In this study, patients treated with ISIS-APOCIII(Rx) achieved average reductions of up to 71 percent in apolipoprotein C-III (apoC-III) and up to 64 percent in triglycerides, and...

2014-03-31 12:02:52

Application of U.S. and European cholesterol guidelines to a European population found that proportions of individuals eligible for statins differed substantially, with one U.S. guideline recommending statins for nearly all men and two-thirds of women, proportions exceeding those of the other guidelines, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions. The common approach in cardiovascular disease (CVD) primary...

2014-03-31 09:39:28

Popular cholesterol-lowering drugs may offer added benefit for men with erectile dysfunction Statins are associated with a significant improvement in erectile function, a fact researchers hope will encourage men who need statins to reduce their risk of heart attack to take them, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. Erectile dysfunction is common in older men, especially among those with cardiovascular risk factors...

Winter's Cold May Lead To Higher Cholesterol Levels: Study
2014-03-28 12:02:26

Brett Smith for redOrbit.com - Your Universe Online Past research has shown that heart attacks and heart-related deaths rise during the winter months and researchers at Johns Hopkins Ciccarone Center for the Prevention of Heart Disease recently found that increased cholesterol levels may be to blame. The new study, which is being presented at the American College of Cardiology's 63rd Annual Scientific Session in Washington, DC this week, is based on cholesterol parameters among a sample...

2014-03-28 08:26:53

U.S. Healthcare Professionals Now Can Perform Lab-Accurate Lipid and Liver Diagnostics with a simple fingerstick using the Piccolo® Blood Chemistry Analyzer. UNION CITY, Calif., March 28, 2014 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the Food and Drug Administration granted CLIA waived status for capillary draw for CHOL, HDL and TRIG. Combined with existing CLIA waived tests for...

2014-03-26 23:31:29

National network of attorneys continues to offer no-cost consultations to consumers over allegations that Lipitor and other statins increase the risk of developing diabetes. San Diego, CA (PRWEB) March 26, 2014 http://www.resource4thepeople.com/defectivedrugs/lipitor-lawsuit.html Resource4thePeople today announced an important legal update for consumers who are interested in litigation involving allegations that the anti-cholesterol medication Lipitor may cause patients to develop...

2014-03-19 08:28:25

CARLSBAD, Calif., March 19, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has initiated a Phase 1 clinical study for ISIS-ANGPTL3(Rx), an antisense drug targeting angiopoietin-like 3 protein (ANGPTL3), an independent risk factor for cardiovascular disease. ISIS-ANGPTL3(Rx) is designed to act as a broad dyslipidemia agent. By reducing ANGPTL3, ISIS-ANGPTL3(Rx) has the potential to reduce LDL-cholesterol and triglycerides, and to increase...

2014-03-13 23:02:07

Center for Primary Care participates in and sponsors the CSRA Heart Walk, raising awareness for cardiovascular disease and heart health. Evans, GA (PRWEB) March 13, 2014 Center for Primary Care recently participated in and sponsored the CSRA Heart Walk. The walk took place at 8:30 a.m. March 8 and raised awareness for cardiovascular disease and heart health. Center for Primary Care was on hand at the walk to offer tips and information for maintaining a healthy heart. Cardiovascular...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related